Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Boehringer Ingelheim invests in China's pet care market
China's pet market is one of the fastest-growing markets in the world.
Move 'an important milestone' for the firm's business development. 

Boehringer Ingelheim has announced that it has acquired an equity stake in the New Ruipeng Group (NRP Group), a fast-growing business that offers digital and clinical pet services across China.

In a press release, Boehringer said the partnership with NRP Group will 'offer better solutions, quality advice and professional care to the growing number of pets and pet owners across China.'

Jean Scheftsik de Szolnok, a member of the board of managing directors with responsibility for Animal Health, said: “Improving the health of animals and humans is what drives us in Boehringer Ingelheim. Strong collaborations and partnerships have always been key to achieving this goal.

“Together with NRP Group and other partners we are looking forward to serving pet owners in China and contributing with our knowledge in areas such as disease understanding or training and education.”

China’s pet market is one of the fastest-growing markets in the world. According to data compiled by Euromonitor International, the Country now has the world’s largest dog and cat population of 188 million.

Rising incomes and urbanisation are thought to be the main reasons why pet ownership in China has become so popular. In turn, this has given rise to a new “pet economy” in which pet owners are said to be continually seeking integrated online and offline products, services and information about their animals.

Boehringer said the move marks 'an important milestone' for the firm's business development in China, adding  that it will continue to invest in China and 'make its contributions to people’s aspirations for integrated and innovative solutions for their pets'.

It continued: 'Boehringer Ingelheim remains fully committed to its current and future business partners, such as other clinics, veterinarians, distributors and animal health companies, and to expanding business opportunities with them. Both companies will continue to work independently according to their respective business models.'

Become a member or log in to add this story to your CPD history

Free CPD announced for BVNA members

News Story 1
 Zoetis is to present a CPD event for free to members of the British Veterinary Nursing Association (BVNA).

Led by veterinary consultant Ruth Moxon, the one-hour online session is designed to help veterinary nurses discuss parasiticide options with clients. It will advise on structuring recommendations, factors for product choice and moving away from 'selling'.

'How do you recommend parasite treatments to your clients?' will be presented on Tuesday, 20 May at 7.30pm. It is free for BVNA members, with 15.00 tickets for non-members.

Veterinary nurses can email cpd@bvna.co.uk to book their place. 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.